A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases
Clinical trial NCT07177950 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07177950
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2028-09-30
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.